The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: BMPR2 vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001204.7(BMPR2):c.1277-9A>G

CA645293838

425917 (ClinVar)

Gene: BMPR2
Condition: pulmonary arterial hypertension
Inheritance Mode: Autosomal dominant inheritance
UUID: bd24bcd2-c2d0-4803-b776-28a371963ce6
Approved on: 2025-05-05
Published on: 2025-05-05

HGVS expressions

NM_001204.7:c.1277-9A>G
NM_001204.7(BMPR2):c.1277-9A>G
NC_000002.12:g.202542302A>G
CM000664.2:g.202542302A>G
NC_000002.11:g.203407025A>G
CM000664.1:g.203407025A>G
NC_000002.10:g.203115270A>G
NG_009363.1:g.170976A>G
ENST00000374580.10:c.1277-9A>G
ENST00000638587.1:c.1208-9A>G
ENST00000374574.2:c.1277-9A>G
ENST00000374580.8:c.1277-9A>G
NM_001204.6:c.1277-9A>G
More

Pathogenic

Met criteria codes 3
PM2_Supporting PS4_Moderate PVS1
Not Met criteria codes 2
BA1 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Pulmonary Hypertension Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for BMPR2 Version 1.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Pulmonary Hypertension VCEP
The BMPR2 c.1277-9A>G variant is a non-canonical splice site (-9) variant located in intron 9. The variant is absent from gnomAD v.2.1.1 and v4.1.0 (PM2_supporting) and was reported in four cases (PMID: 18356561, 20534176, 27613157) (PS4_moderate). In silico prediction (SpliceAI) indicates likely loss of the acceptor splice site (score = 0.97). cDNA analysis demonstrates an aberrant splice product leading to premature truncation (p.Gly426Aspfs*47) and, thus, likely nonsense mediated decay (PMID: 18356561 and private communication: Soubrier) (PVS1 (RNA)). No familial segregation data were available. In summary, the variant meets the criteria to be classified as pathogenic for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PVS1 (RNA), PM2_supporting, PS4_moderate (VCEP specification version v1.1, 1/18/2024).
Met criteria codes
PM2_Supporting
Variant is absent from controls (gnomAD v2.1.1 and v4.1.0)
PS4_Moderate
Variant is observed in four ostensibly unrelated individuals with PAH
PVS1
cDNA sequence analysis shows that the variant has an effect on splicing, which has been confirmed via private communication (Prof. Florent Soubrier) as resulting in premature truncation of the translated protein (p.Gly426Aspfs*47)
Not Met criteria codes
BA1
Variant is not present in gnomAD v2.1.1 and v4.1.0
BS1
Variant is not present in gnomAD v2.1.1 and v4.1.0
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.